[go: up one dir, main page]

AU2003232652A1 - Oral controlled-release dosage forms containing acetaminophen - Google Patents

Oral controlled-release dosage forms containing acetaminophen

Info

Publication number
AU2003232652A1
AU2003232652A1 AU2003232652A AU2003232652A AU2003232652A1 AU 2003232652 A1 AU2003232652 A1 AU 2003232652A1 AU 2003232652 A AU2003232652 A AU 2003232652A AU 2003232652 A AU2003232652 A AU 2003232652A AU 2003232652 A1 AU2003232652 A1 AU 2003232652A1
Authority
AU
Australia
Prior art keywords
dosage forms
release dosage
forms containing
oral controlled
containing acetaminophen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003232652A
Inventor
Qing-Ri Cao
Youn-Woong Choi
Beom-Jin Lee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Seoul Pharm Co Ltd
Original Assignee
Seoul Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seoul Pharm Co Ltd filed Critical Seoul Pharm Co Ltd
Publication of AU2003232652A1 publication Critical patent/AU2003232652A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AU2003232652A 2002-07-16 2003-05-27 Oral controlled-release dosage forms containing acetaminophen Abandoned AU2003232652A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR10-2002-0041469A KR100522239B1 (en) 2002-07-16 2002-07-16 Compositions for controlled release acetaminophen dosage forms
KR10-2002-0041469 2002-07-16
PCT/KR2003/001036 WO2004006904A1 (en) 2002-07-16 2003-05-27 Oral controlled-release dosage forms containing acetaminophen

Publications (1)

Publication Number Publication Date
AU2003232652A1 true AU2003232652A1 (en) 2004-02-02

Family

ID=30113186

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003232652A Abandoned AU2003232652A1 (en) 2002-07-16 2003-05-27 Oral controlled-release dosage forms containing acetaminophen

Country Status (3)

Country Link
KR (1) KR100522239B1 (en)
AU (1) AU2003232652A1 (en)
WO (1) WO2004006904A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100676298B1 (en) * 2005-08-24 2007-01-30 씨제이 주식회사 Solid dispersion and preparation method thereof
KR100704008B1 (en) * 2005-11-23 2007-04-04 파미래 주식회사 Oral preparations containing silinidipine and preparation method thereof
EP1935411A1 (en) * 2006-12-15 2008-06-25 Campina Nederland Holding B.V. Slow release excipient and its use
KR100944121B1 (en) * 2007-09-28 2010-02-24 대원제약주식회사 Fast-acting pharmaceutical composition comprising soy polysaccharide
AU2008314454A1 (en) 2007-10-16 2009-04-23 Labopharm (Barbados) Limited Bilayer composition for the sustained release of acetaminophen and tramadol
WO2009076764A1 (en) 2007-12-17 2009-06-25 Labopharm Inc. Misuse preventative, controlled release formulation
JP2011511782A (en) 2008-02-12 2011-04-14 アボット・ラボラトリーズ Extended release hydrocodone acetaminophen and related methods and uses
ES2509497T3 (en) 2008-12-16 2014-10-17 Paladin Labs Inc. Controlled release formulation to prevent misuse
CZ302789B6 (en) * 2009-11-25 2011-11-09 Zentiva, K. S. Method of increasing solubility of pharmaceutically active compounds and targeted (controlled) transport thereof into intestine
CA2856677A1 (en) * 2012-01-04 2013-07-11 Wellesley Pharmaceuticals, Llc Extended-release formulation for reducing the frequency of urination and method of use thereof
JP2015537029A (en) 2012-11-14 2015-12-24 ダブリュー・アール・グレース・アンド・カンパニー−コーンW R Grace & Co−Conn Composition containing biologically active substance and irregular inorganic oxide
DK3069733T3 (en) * 2013-11-13 2022-11-14 National Defense Education And Res Foundation NEW ACETAMINOPHYDRATE COMPOUND WITH NO LIVER SIDE EFFECTS
WO2016042570A1 (en) * 2014-09-16 2016-03-24 Suresh Pareek Extended release formulation of acetaminophen
WO2019088669A1 (en) 2017-10-31 2019-05-09 주식회사 삼양바이오팜 Oral solid dosage form composition having improved disintegration and preparation method therefor
JP6858729B2 (en) * 2018-05-25 2021-04-14 ▲財▼▲団▼法人国防教育研究基金会National Defense Education And Research Foundation New acetaminophen complex composition with no side effects on the liver
KR102168395B1 (en) * 2018-10-30 2020-10-22 한양대학교 에리카산학협력단 Solid dispersion of sildenafil free base having improved solubility and method for preparing the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820522A (en) * 1987-07-27 1989-04-11 Mcneilab, Inc. Oral sustained release acetaminophen formulation and process
US6149953A (en) * 1993-11-08 2000-11-21 Delta Food Group, Inc. Seeded microcapsules
US5948438A (en) * 1995-01-09 1999-09-07 Edward Mendell Co., Inc. Pharmaceutical formulations having improved disintegration and/or absorptivity
US5733578A (en) * 1995-11-15 1998-03-31 Edward Mendell Co., Inc. Directly compressible high load acetaminophen formulations
US6254891B1 (en) * 1998-09-03 2001-07-03 Ascent Pediatrics, Inc. Extended release acetaminophen

Also Published As

Publication number Publication date
WO2004006904A1 (en) 2004-01-22
KR100522239B1 (en) 2005-10-18
KR20040006887A (en) 2004-01-24

Similar Documents

Publication Publication Date Title
AU2003303518A1 (en) Hand held oral irrigator
GB0218625D0 (en) Pharmaceutical compounds
IL175193A0 (en) Once-a-day, oral, controlled-release, oxycodone dosage forms
AU2003291103A1 (en) Pharmaceutical composition
AU2003238670A1 (en) Fast disintegrating oral dosage forms
PL377495A1 (en) Solid drug for oral use
AU2003232652A1 (en) Oral controlled-release dosage forms containing acetaminophen
AU2003250372A1 (en) Pharmaceutical composition
GB0215775D0 (en) Pharmaceutical compounds
AU2003241671A1 (en) Controlled-release drug composition
AU2003276572A1 (en) Pharmaceutical dosage forms of biguanide-sulfonylurea combinations
HUP0500638A3 (en) Flashmelt oral dosage formulation
AU2003249105A1 (en) Processes for the preparation of oral dosage formulations of modafinil
AU2003225285A1 (en) Oral dosage forms comprising fenofibrate
AU2003290436A1 (en) Oral preparation system
AU2003244942A1 (en) Controlled-release pharmaceutical formulations
AU2003252683A1 (en) Composition for oral use
IL166337A0 (en) Oral administration of calctionin
AU2003211586A1 (en) Drugs containing riboflavin-type compounds
AU2003265680A1 (en) Oral liquid tolterodine composition
AU2002251448A1 (en) Oral absorbed drugs
AU2003291600A1 (en) Pharmaceutical formulations containing nitrate
AU2003247001A1 (en) Processes for the preparation of oral dosage formulations of modafinil
GB0204392D0 (en) Pharmaceutical compound
AU2003223901A1 (en) Deuterated substituted indoles and medicaments containing said compounds

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase